Latest Blogs

Feb 14, 2019
It's hard enough to try dating again after a cancer diagnosis and treatment, but some of my patients also face strong opposition from their adult children.
Feb 14, 2019
Dr. Suneel D. Kamath was surprised to learn how important laughter and levity can be in the physician-patient relationship.
Feb 11, 2019
When a patient asks, "Why me?", Dr. Stephanie Graff considers that they may not be asking for a list of their cancer risk factors.
Feb 07, 2019
Dr. Gottlieb discusses the FDA's efforts to increase overall efficiency by updating or modernizing aspects of our clinical trials conduct and expediting the end-to-end drug development process, as well as controlling the next generation of tobacco products.
Subscribe to this column

George W. Sledge, MD, FASCO

George W. Sledge, Jr., MD, FASCO, is Chief of the Division of Oncology and Professor of Medicine at Stanford University School of Medicine. Prior to joining Stanford, he was Co-Director of the Breast Cancer Program as well as the Ballve-Lantero Professor of Oncology and Professor of Medicine and Pathology at the Indiana University Simon Cancer Center. He was the 2010-2011 President of ASCO, and he has served on numerous ASCO committees. He has also served as Chair of the Breast Committee of the Eastern Cooperative Oncology Group from 2002-2009. Dr. Sledge is currently a member of the Measures Task Force, as well as the Quality of Care and CancerLinQ Patient Reported Outcomes Committees. He received the 2006 Komen Foundation Brinker Award for Scientific Distinction in 2006, The Breast Cancer Research Foundation Jill Rose Award, and the William L. McGuire Award from the San Antonio Breast Cancer Symposium in 2010.

Nov 24, 2011
The essayist Christopher Hitchens is battling esophageal cancer, and like most fighting that battle, appears to be losing: he calls this “the year of living dyingly.” His writing on his encounters with the disease have been morbidly funny and heartfelt. I recently came across...
Nov 20, 2011
The Institute of Medicine is the branch of the National Academy of Sciences that serves, in the words of its own website, as “an independent, nonprofit organization that works outside of government to provide unbiased and authoritative advice to...
Nov 13, 2011
My good friend Cliff Hudis has sent me a report from the New York Times announcing the passing of Evelyn Lauder, at the age of 75, from complications stemming...
Nov 06, 2011
The ABC1 conference has been going on in Lisbon, Portugal, for the past three days. ABC stands for Advanced Breast Cancer, and the conference has been a mix of didactic lectures (on all things metastatic) and guideline development. It’s the...
Oct 28, 2011
I’ve been traveling the last few days, attending the Breast Cancer Research Foundation’s annual meeting in New York followed by the Penn State Hershey Cancer Institute’s...
Oct 14, 2011
When I try to explain clinical science to laboratory scientists I always start by asking them the following question: “Imagine that, in doing a controlled experiment, it took two years to get approval to run the experiment, that the control arm was highly variable in its genetic background, that...